862 related articles for article (PubMed ID: 34621670)
1. Integration of scRNA-Seq and Bulk RNA-Seq to Analyse the Heterogeneity of Ovarian Cancer Immune Cells and Establish a Molecular Risk Model.
Liang L; Yu J; Li J; Li N; Liu J; Xiu L; Zeng J; Wang T; Wu L
Front Oncol; 2021; 11():711020. PubMed ID: 34621670
[TBL] [Abstract][Full Text] [Related]
2. Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq.
Zhang D; Lu W; Cui S; Mei H; Wu X; Zhuo Z
J Ovarian Res; 2022 Nov; 15(1):123. PubMed ID: 36424614
[TBL] [Abstract][Full Text] [Related]
3. Integration of scRNA-Seq and TCGA RNA-Seq to Analyze the Heterogeneity of HPV+ and HPV- Cervical Cancer Immune Cells and Establish Molecular Risk Models.
Wei E; Reisinger A; Li J; French LE; Clanner-Engelshofen B; Reinholz M
Front Oncol; 2022; 12():860900. PubMed ID: 35719936
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model.
Tan Z; Chen X; Zuo J; Fu S; Wang H; Wang J
J Transl Med; 2023 Mar; 21(1):223. PubMed ID: 36973787
[TBL] [Abstract][Full Text] [Related]
5. Construction of a New Ferroptosis-related Prognosis Model for Survival Prediction in Colorectal Cancer.
Chen L; Ge M; Mo S; Shi M; Zhang J; Liu J
Curr Med Chem; 2024 Feb; ():. PubMed ID: 38362684
[TBL] [Abstract][Full Text] [Related]
6. Analysis on heterogeneity of hepatocellular carcinoma immune cells and a molecular risk model by integration of scRNA-seq and bulk RNA-seq.
Liu X; Li J; Wang Q; Bai L; Xing J; Hu X; Li S; Li Q
Front Immunol; 2022; 13():1012303. PubMed ID: 36311759
[TBL] [Abstract][Full Text] [Related]
7. Identification of an Autophagy-Related Signature for Prognosis and Immunotherapy Response Prediction in Ovarian Cancer.
Ding J; Wang C; Sun Y; Guo J; Liu S; Cheng Z
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830707
[TBL] [Abstract][Full Text] [Related]
8. Development and validation a prognostic model based on natural killer T cells marker genes for predicting prognosis and characterizing immune status in glioblastoma through integrated analysis of single-cell and bulk RNA sequencing.
Hu J; Xu L; Fu W; Sun Y; Wang N; Zhang J; Yang C; Zhang X; Zhou Y; Wang R; Zhang H; Mou R; Du X; Li X; Hu S; Xie R
Funct Integr Genomics; 2023 Aug; 23(3):286. PubMed ID: 37650991
[TBL] [Abstract][Full Text] [Related]
9. ScRNA-seq and bulk RNA-seq reveal the characteristics of ferroptosis and establish a risk signature in cholangiocarcinoma.
Yao W; Liu X; He Y; Tian M; Lu S; Wang Q; Zheng Y; Lv Z; Hao C; Xue D; Meng X
Mol Ther Oncolytics; 2022 Dec; 27():48-60. PubMed ID: 36284715
[TBL] [Abstract][Full Text] [Related]
10. CXCR4 Expressed by Tumor-Infiltrating B Cells in Gastric Cancer Related to Survival in the Tumor Microenvironment: An Analysis Combining Single-Cell RNA Sequencing with Bulk RNA Sequencing.
Su C; Yu R; Hong X; Zhang P; Guo Y; Cai JC; Hou J
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629071
[TBL] [Abstract][Full Text] [Related]
11. Single-cell and WGCNA uncover a prognostic model and potential oncogenes in colorectal cancer.
Di Z; Zhou S; Xu G; Ren L; Li C; Ding Z; Huang K; Liang L; Yuan Y
Biol Proced Online; 2022 Sep; 24(1):13. PubMed ID: 36117173
[TBL] [Abstract][Full Text] [Related]
12. Integration of single-cell RNA-seq and bulk RNA-seq data to construct and validate a cancer-associated fibroblast-related prognostic signature for patients with ovarian cancer.
Shen L; Li A; Cui J; Liu H; Zhang S
J Ovarian Res; 2024 Apr; 17(1):82. PubMed ID: 38627854
[TBL] [Abstract][Full Text] [Related]
13. Integrative analysis reveals a four-gene signature for predicting survival and immunotherapy response in colon cancer patients using bulk and single-cell RNA-seq data.
Chai R; Zhao Y; Su Z; Liang W
Front Oncol; 2023; 13():1277084. PubMed ID: 38023180
[TBL] [Abstract][Full Text] [Related]
14. Glycosylation-related genes mediated prognostic signature contribute to prognostic prediction and treatment options in ovarian cancer: based on bulk and single‑cell RNA sequencing data.
You Y; Yang Q
BMC Cancer; 2024 Feb; 24(1):207. PubMed ID: 38355446
[TBL] [Abstract][Full Text] [Related]
15. A novel prognostic model based on single-cell RNA sequencing data for hepatocellular carcinoma.
Lu J; Chen Y; Zhang X; Guo J; Xu K; Li L
Cancer Cell Int; 2022 Jan; 22(1):38. PubMed ID: 35078458
[TBL] [Abstract][Full Text] [Related]
16. Integrative Analysis of Single-Cell and Bulk RNA Sequencing Reveals Prognostic Characteristics of Macrophage Polarization-Related Genes in Lung Adenocarcinoma.
Mi K; Zeng L; Chen Y; Yang S
Int J Gen Med; 2023; 16():5031-5050. PubMed ID: 37942473
[TBL] [Abstract][Full Text] [Related]
17. Integration of Single-Cell RNA Sequencing and Bulk RNA Sequencing Data to Establish and Validate a Prognostic Model for Patients With Lung Adenocarcinoma.
Jiang A; Wang J; Liu N; Zheng X; Li Y; Ma Y; Zheng H; Chen X; Fan C; Zhang R; Fu X; Yao Y
Front Genet; 2022; 13():833797. PubMed ID: 35154287
[No Abstract] [Full Text] [Related]
18. Integrating single-cell and bulk RNA sequencing data unveils antigen presentation and process-related CAFS and establishes a predictive signature in prostate cancer.
Wang W; Li T; Xie Z; Zhao J; Zhang Y; Ruan Y; Han B
J Transl Med; 2024 Jan; 22(1):57. PubMed ID: 38221616
[TBL] [Abstract][Full Text] [Related]
19. Construction of cancer- associated fibroblasts related risk signature based on single-cell RNA-seq and bulk RNA-seq data in bladder urothelial carcinoma.
Liu Y; Jian J; Zhang Y; Wang L; Liu X; Chen Z
Front Oncol; 2023; 13():1170893. PubMed ID: 37124542
[TBL] [Abstract][Full Text] [Related]
20. Identification of CD8
Li L; Chen D; Luo X; Wang Z; Yu H; Gao W; Zhong W
Front Genet; 2022; 13():860161. PubMed ID: 35711935
[No Abstract] [Full Text] [Related]
[Next] [New Search]
